CDTX - Cidara Therapeutics GAAP EPS of -$0.27 beats by $0.01 revenue of $7.11M beats by $2.4M May, 11 2022 04:56 PM Cidara Therapeutics Inc. Cidara Therapeutics press release (NASDAQ:CDTX): Q1 GAAP EPS of -$0.27 beats by $0.01. Revenue of $7.11M (+195.0% Y/Y) beats by $2.4M. Shares +4.22%. For further details see: Cidara Therapeutics GAAP EPS of -$0.27 beats by $0.01, revenue of $7.11M beats by $2.4M